Oppenheimer & Co. Inc. announced that Joel Berry II, a former college basketball star and professional player, has joined its Robinson Private Client Group as a Financial Advisor. Berry will focus on advising current and former athletes, including student-athletes navigating Name, Image, and Likeness (NIL) opportunities. His experience as an athlete is expected to enhance the group's services for high-net-worth individuals and families in the sports industry.
IDEAYA Biosciences berencana untuk memulai uji coba klinis Fase 3 untuk IDE849, obat kanker paru-paru sel kecil stadium lanjut (ES-SCLC), pada akhir tahun 2026. Keputusan ini menyusul pertemuan positif dengan FDA mengenai desain uji coba. Uji coba in...
Hannan Metals announced strong assay results from its first drill program at the Stavaträsk gold project in northern Sweden, confirming gold mineralization in all seven holes over 650 meters of strike. The deepest hole, ST2606, returned the best inte...
Jazz Pharmaceuticals announced positive results from its HERIZON-GEA-01 trial, showing that Ziihera, combined with chemotherapy, significantly improved overall survival in adults with HER2-positive gastroesophageal adenocarcinoma (GEA) compared to th...
As credit spreads narrow to near historical lows, many high-yield bond ETFs offer reduced risk-adjusted returns, making them less compelling buys. However, three ETFs—CEFS, CLOZ, and JEMB—remain attractive. CLOZ offers the highest dividend yield at 7...
Sylvamo is currently experiencing temporary challenges including weak European markets, lost production capacity, operational issues, and high capital expenditures, leading to low earnings and free cash flow. However, supply cuts in North America, ta...
